The revolutionary BiVACOR heart device was moved to Phase 2 of FDA trials after success in five human patients.

Heart disease, also called cardiovascular disease, can have serious consequences. It's the leading cause of death for adults in the U.S. Medical devices approved by the U.S. Food and Drug ...

After several years and about $6 million later, MultiCare Good Samaritan Hospital in Puyallup has achieved a development milestone with a new hybrid operating room. The room can convert into a cardiac ...

EW stock is on investors' radars due to the promising structural heart opportunities following the divestment of the Critical Care arm.

It’s Heart Health Month and we’re discussing what you need to know about a potentially lifesaving approach to treat a heart ...

Valeo Financial Advisors LLC increased its position in Edwards Lifesciences Co. (NYSE:EW – Free Report) by 11.3% in the fourth quarter, according to the company in its most recent Form 13F filing with ...

Edwards Lifesciences Corporation (NYSE:EW), a leading medical technology company specializing in heart valve therapies and critical care technologies with a market capitalization of $44.9 billion, has ...

The tricuspid valve is anatomically complex. It’s often called the “forgotten valve” because of its position in the back of ...

Investment analysts at Leerink Partnrs lowered their Q1 2025 earnings per share estimates for shares of Edwards Lifesciences ...